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X‑ray microtomography 
is a novel method for accurate 
evaluation of small‑bowel mucosal 
morphology and surface area
Johannes Virta1,2, Markus Hannula3, Ilmari Tamminen3, Katri Lindfors4, Katri Kaukinen4,5, 
Alina popp6, Juha Taavela7, Päivi Saavalainen8, Pauliina Hiltunen1,2, Jari Hyttinen3 & 
Kalle Kurppa1,2,9*
The often poorly orientated small-bowel mucosal biopsies taken for the diagnostics of celiac 
disease and other intestinal disorders are prone to misinterpretation. Furthermore, conventional 
histopathology has suboptimal sensitivity for early histopathological changes observed in short‑term 
challenge studies. X‑ray microtomography (micro‑ct) is a promising new method for accurate imaging 
of human-derived biological samples. Here, we report that micro-CT could be utilized to create virtual 
reconstructions of endoscopically obtained intestinal biopsies. The formed digital 3D images enabled 
selection of always optimal cutting angles for accurate measurement of the mucosal damage and 
revealed diagnostic lesions in cases interpreted as normal with conventional histomorphometry. We 
also demonstrate that computer‑assisted point cloud analysis can be used to calculate biologically 
meaningful surface areas of the biopsies in different stages of mucosal damage with excellent 
replicability and correlation with other disease parameters. We expect the improved diagnostic 
accuracy and capability to measure the surface areas to provide a powerful tool for the diagnostics of 
intestinal diseases and for future clinical and pharmaceutical trials.
Correct identification of celiac disease is essential, as misdiagnosis may lead to morbidity related either to ongo-
ing duodenal damage or to unnecessary dietary restriction. The diagnosis has traditionally been based on the 
histopathologic evaluation of small-bowel mucosal biopsies. Since this is conducted on cross-sectional cuttings of 
the original 3D sample, precise orientation of the specimen is critical, but often difficult (Supplementary Fig. 1). 
Further challenges are caused by patchiness of the lesion and significant intra- and interobserver variation in 
the grouped histopathology routinely  applied1–4. There is a preference for a less invasive diagnostic approach, at 
least in Europe, but the biopsy remains obligatory in adults and in children with low positive celiac serology, i.e. 
in the diagnostically most challenging  cases5,6. Besides the diagnosis, improved histological assessment would 
be welcomed for pharmaceutical  studies7.
An interesting new imaging method for biological samples is X-ray microtomography (micro-CT). Exami-
nation of the small intestine can nowadays be done with conventional CT, but micro-CT imaging for human 
derived biopsies has not yet been  tested8–10. Micro-CT enables virtual 3D modeling and cross sectioning of the 
original specimen at arbitrary angles without destroying  it11,12. The often encountered low tissue contrast can be 
improved by contrast enhancement  reagents13,14. The generated 3D image allows free rotation and digital cut-
ting, which, in the case in small-bowel mucosal samples, could enable optimal orientation of the villi for exact 
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morphometry. It might even be possible to measure surface areas for more sensitive and biologically meaningful 
estimations of the mucosal health. Moreover, we hypothesized that, if successful in paraffin-embedded biopsies, 
micro-CT could be used to re-evaluate archived samples taken even years earlier. However, micro-CT imaging 
has not so far been tested with human-derived intestinal samples.
We investigated whether micro-CT imaging could be utilized to improve the accuracy of the morphometric 
analyses of small-bowel mucosal biopsies and with distinguishing between healthy and diseased states, particu-
larly in subjects with suspected celiac disease. Additionally, as a completely novel approach to attain precise 
information of the mucosal changes, we explored the possibility of performing surface area measurements from 
the digitalized biopsies.
Materials and methods
patients and study design. The study was carried out at Tampere University and Tampere University 
Hospital. Biopsies for micro-CT imaging were selected from among samples taken from individuals who had 
undergone esophagogastroduodenoscopy with duodenal sampling and who had given their consent to partici-
pate in research projects. The selected subjects represented different stages of small-bowel changes from mor-
phologically normal villi to severely diseased mucosa, as determined in conventional histology. All subjects 
with positive celiac disease serology started a gluten-free diet, either as a treatment after diagnosis or as an 
experimental  trial15. Besides the endoscopy, supplementary laboratory measurements, including measurement 
of celiac disease serology and genetics, were carried out. Repeat biopsies were obtained after approximately one 
year on a gluten-free diet. The diagnosis of celiac disease was based on the detection of small-bowel mucosal 
 atrophy16. The Regional Ethics Committee of Pirkanmaa Hospital District approved the study protocol and 
patient recruitment. All participants gave written informed consent. Patients or the public were not involved in 
the design, or conduct, or report or dissemination of our research. All experiments were performed in accord-
ance with relevant guidelines and regulations.
celiac disease serology and genetics. Serum autoantibodies to transglutaminase 2 (TG2ab) were meas-
ured by commercial ELISA assay (Phadia AB, Uppsala, Sweden) with values ≥ 5.0  U/ml considered positive. 
Serum endomysium antibodies (EmA) were measured by indirect immunofluorescence using human umbili-
cal cord as a  substrate17. A titer of 1: ≥ 5 for EmA was considered positive and further diluted up to 1:4,000 
until negative. Celiac disease-associated gene alleles encoding HLA-DQ2 and DQ8 were analyzed as described 
 elsewhere15,18.
Endoscopies, histopathology, and immunohistochemistry. All esophagogastroduodenoscopies 
were performed using a standard endoscope (Olympus Corp., Tokyo, Japan) and routine sampling techniques. 
At least four forceps biopsies were systemically obtained from the duodenum and referred for conventional his-
topathologic analysis. In addition, several biopsies were taken for research purposes. Processing of the research 
biopsies was carried out according to their further use as described below.
In addition, histology was assessed with validated  histomorphometry3. The biopsies were formalin-fixed, 
embedded in paraffin conventionally via increasing ethanol-dehydration series and xylene, cut in 2 µm sections, 
and stained with hematoxylin–eosin (H&E) (Fig. 1). Special attention was paid to the correct orientation and 
only sections containing longitudinally cut crypts were accepted for further analyses. Recuttings were requested 
until apparently acceptable morphometric readouts were obtained. Quantitative villous height/crypt depth ratio 
(VH:CrD) was analyzed as an average of at least three individual crypt-villous pairs, considering a VH:CrD < 2.0 
diagnostic for celiac  disease3.
A subset of the duodenal biopsies was snap-frozen and used for immunofluorescent determination of 
small-bowel mucosal TG2-targeted immunoglobulin A (IgA) deposits. After sampling the biopsies were freshly 
embedded in optimal cutting temperature compound (Tissue-Tec, Miles, Elkhart, IN) and snap-frozen in liq-
uid nitrogen. The deposits were investigated from 5 µm thick frozen sections by double-labeling TG2 and IgA 
as previously  described16. The deposits have been shown to have an excellent specificity for celiac disease even 
before manifest morphological  lesion19.
processing and micro‑ct imaging of the duodenal biopsies. Before micro-CT imaging, excess par-
affin was removed from the paraffin-embedded biopsies around the actual tissue, and the remaining sample was 
placed in contrast-enhancing iodine-based solution  (I2E) (Fig. 1)20. The solution was made by dissolving solid 
iodine (207772, Sigma Aldrich, MO) in absolute ethanol to achieve a concentration of 10 mg/ml. Solution times 
of 3–25 h were tested to ensure sufficient saturation for optimal contrast enhancement throughout the sample. 
Next, the samples were placed in 1 ml plastic syringe and stabilized between rubber pistons. The syringe was 
filled with the  I2E to preserve the chemical conditions and to eliminate outward diffusion of the contrast agent. 
Chemical and mechanical stability of the sample was monitored by collecting a set of images (drift file) from a 
fixed angle during imaging. In order to test for possible faster tissue saturation, a subset of duodenal biopsies 
were imaged without paraffin embedding and, instead of the xylene step, by transferring the samples directly to 
the  I2E.
All micro-CT images were acquired by MicroXCT-400 device (Xradia, Carl Zeiss AG, CA). The protocol was 
optimized by testing X-ray acceleration voltages of 40 kV, 60 kV, 80 kV and 100 kV with and without filtering, 
aiming to achieve optimal image resolution and contrast within a practical period of time. Image quality was 
assessed visually as in standard histopathology. To create 3D images, the data were reconstructed by XMRe-
constructor 8.1.6599 software (Xradia). Avizo software (Thermo Fisher Scientific, Waltham, MA) was used to 
produce example videos of the digital cutting and morphometric evaluation of the 3D images.
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Figure 1.  Comparison of conventional histology and micro-CT imaging of the small-bowel mucosal biopsies. 
After sampling, the specimen is fixed with formalin and dehydrated with increasing ethanol series. Next, in 
conventional histology (left route), the biopsy is embedded in paraffin via xylene and then cut into thin sections, 
stained with H&E, and evaluated under light microscopy. The assessment is performed either applying grouped 
 classification42 or by quantitative determination of the villous height-crypt depth  ratio3. Correct orientation 
of the biopsy is a prerequisite for reliable measurements. This is accomplished by recutting the sections until 
acceptable readouts are obtained, assuming that the biopsy size is sufficient for this. Micro-CT imaging (right 
route) starts by placing fixed and ethanol-dehydrated biopsies with or without paraffin embedding into  I2E 
solution to increase the intrinsically low soft tissue contrast. Subsequently, mechanically stabilized biopsy is 
scanned using X-ray source and detector, and the acquired transmission images are reconstructed to 3D model. 
The model is freely orientable for precise morphometric measurements and also enables measurement of the 
mucosal surface areas.
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Surface area measurements. The surface area of a selected 3D biopsy model was measured by applying 
computer-assisted point cloud analysis with Avizo software (Thermo Fisher Scientific, Waltham, MA). First, the 
3D image was denoised to refine surface of the sample for the point cloud  analyzes21. According to out prior 
experience Non-local filter was used for this task. Median filter was also tested but it did not provide additional 
benefits over Non-local filter. Then the tissue area was segmented from the background using manual threshold-
ing. Next, analysis of the effective surface area was carried out by aligning a rectangle of predefined size with the 
mucosa and perpendicular to the villi. The point cloud of the tissue surface provided by segmentation was used 
to calculate the surface within these boundaries. The surface area was calculated using discretized generalization 
of the Crofton formula to 3D point cloud (Fig. 4)22. The measured area was compared with that of an equal but 
completely flat rectangle according to the following equation:
Next, the result was given as a coefficient to this theoretical minimum value of 1.0.
In order to evaluate the optimal margins and replicability of the measures, squares with increasing side lengths 
from 0.1 to 1.0 mm at every 0.1 mm were tested by measuring 20 individual measurements from the same biopsy 
and counting the means and 95% confidence intervals. This was done in three separate biopsies representing 
severe mucosal damage, less advanced lesion and normal morphology based on VH:CrD (Supplementary Fig. 2).
Results
patient characteristics and histomorphometry. The study comprised eight subjects who had under-
gone duodenal sampling due to various symptoms and signs; the six cases with positive celiac autoantibodies 
also underwent repeat biopsy after approximately 1 year on a gluten-free diet (Table 1). After the conventional 
histopathology with quantitative morphometry, three subjects received a celiac disease diagnosis, three had 
potential celiac disease with positive TG2ab and EmA and VH:CrD > 2.0, and the two seronegative subjects had 
normal villi (Table 1). All seropositive cases had celiac disease-associated HLA-DQ2/DQ8 and positive mucosal 
IgA deposits, and demonstrated clinical and serological response to the dietary treatment (Table 1). One of the 
seronegative subjects had HLA-DQ2 and the other was negative for both predisposing alleles. Duodenal histo-
morphometry improved in all celiac disease patients on a gluten free diet. Furthermore, despite the allegedly 
normal villi at baseline, VH:CrD also increased in cases with potential celiac disease (Table 1).
Micro-CT imaging. Sufficient tissue saturation was achieved when the paraffin-embedded biopsy was 
placed in the  I2E solution for 12 h. Both whole and partially microtomed paraffin biopsies could be utilized. In 
order to achieve complete  I2E saturation, excess paraffin had to be removed from around the samples. Although 
saturation could theoretically be faster without paraffin embedding, there was no significant difference in image 
quality between biopsies with and without paraffin after contrast enhancement. In fact, the paraffin-stabilized 
samples showed sample-movement artifacts less often, and were thus used for the study. It was also possible to 
conduct conventional histopathology after micro-CT imaging, although the samples were more brittle due to 
the  I2E treatment.
Effective surface area =
Measured surface area from selected rectangle
(
mm
2
)
Area of selected rectangle
(
mm2
)
Table 1.  Clinical, serological and histological characteristics of the study patients. CD celiac disease, EmA 
endomysium antibodies, GFD gluten-free diet, tTGab tissue transglutaminase antibodies, VH/CrD villous 
height crypt depth ratio. a Reference value < 5.0 U/l. b In relation to the theoretical minimum value of 1.0 of 
perfectly flat mucosa.
No: Age, years Sex Indication for endoscopy EmA, titer tTGab, U/la
Histomorphometry Micro-CT imaging
VH/CrD Diagnosis VH/CrD Surface  areab Diagnosis
1 67 F Diarrhea, bloating 1:1,000 42.1 0.1 CD 0.8 2.8 CD
68 Repeat biopsy on a GFD Negative 3.0 2.5 Healed CD 2.2 6.0 Healed CD
2 45 M Protein-losing enteropathy 1:4,000 > 100.0 1.3 CD 0.5 1.8 CD
46 Repeat biopsy on a GFD 1:200 26.4 2.6 Healed CD 2.1 6.1 Healed CD
3 68 F Unexplained anemia 1:200 89.8 0.1 CD 0.1 1.3 CD
69 Repeat biopsy on a GFD Negative 2.4 0.4 Improved CD 0.9 3.3 Improved CD
4 39 M Diarrhea, bloating 1:5 7.7 2.2 Potential CD 1.0 2.1 CD
40 Repeat biopsy on a GFD Negative 0.3 4.3 Healed CD? 2.7 5.9 Healed CD
5 46 F Abdominal pain, bloating 1:5 4.6 2.3 Potential CD 1.3 3.2 CD
47 Repeat biopsy on a GFD Negative 0.6 2.8 Healed CD? 2.0 5.6 Healed CD
6 44 F Diarrhea, abdominal pain 1:50 6.8 3.0 Potential CD 2.6 3.8 Potential CD
45 Repeat biopsy on a GFD Negative 2.1 3.3 Healed CD? 2.9 5.9 Healed CD?
7 65 F Dyspepsia Negative 0.6 2.8 No CD 2.6 4.4 No CD
8 53 M Dyspepsia Negative 0.8 2.8 No CD 2.5 5.9 No CD
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After optimization of the procedures, we decided to use non-filtered X-ray radiation with 100 kV accelera-
tion voltage and 10 W source power for the imaging. The chosen 100 kV provided clearly sufficient quality 
with a reasonable imaging time. Despite the relatively high voltage, no beam hardening was observed in the 
3D reconstructions. Altogether 1,600 X-ray projections were evenly acquired 360° around each sample with 
5 s exposure time per image. Use of X-ray detection scintillator with 10 × objective and binning 2 gave a voxel 
size of approximately 2 μm. The subsequently reconstructed 3D digital biopsies accurately showed the general 
appearance and main tissue features of the duodenal mucosa (Fig. 2).
Furthermore, the 3D biopsies could be freely manipulated and digitally cut back into slices with optimal plane 
of viewing for precise morphometric measurements of the villi and crypts (Fig. 2, Video 1, Video 2).
Comparisons between conventional histology, histomorphometry, and micro-CT. Figure  3 
shows the H&E stained sections used for routine histopathology, the corresponding cuttings evaluated by quan-
titative morphometry, and the digital sections obtained by micro-CT. The figure demonstrates the frequently 
poor biopsy quality and incorrect cutting angle in the routine sections, revealed by circular sections of the 
mucosal crypts. Utilization of these sections in the diagnostics increases the risk of misinterpretation and they 
should not be used for diagnostic evaluation. Images in the middle sections of Fig.  3 are clearly better ori-
entated with the longitudinally cut crypts indispensable for accurate  histomorphometry3. However, achieving 
these results required several laborious re-evaluations and, in fact, in many cases remained suboptimal, as it was 
impossible to further recut biopsies of limited size. Patchiness within the biopsies and difficulties in acquiring 
evenly distributed longitudinal cuttings of the crypts further hampered the analysis of borderline cases, particu-
larly as it was often impossible to further recut biopsies of limited size.
The 3D micro-CT reconstructions of the biopsies allowed easy and accurate digital sectioning in each case 
(Fig. 3). The resulting improved diagnostic accuracy actually revealed a clear celiac-type lesion in two patients, 
as well as their morphometric healing on GFD (cases 4 and 5 in Fig. 3). Furthermore, the orientation of the 
individual villi varied within a single biopsy, and to make truly precise measurements each villus needed to be 
cross-sectioned separately instead of a singular plane of view, which was possible only with micro-CT recon-
structions. The resolution was somewhat lower than with H&E stainings, but sufficient for the determination of 
VH/CrD. Micro-CT analysis changed the result in seven subjects; in all but one to a more severe lesion (Table 1). 
Moreover, in accord with the clinical, serological and histological response to gluten-free diet, two cases with 
potential celiac disease in conventional histology showed diagnostic lesion in digital cutting (Table 1, Fig. 3). 
The general appearance of surface of the 3D biopsy models obtained from these subjects was already markedly 
different from that of the non-celiac controls (Fig. 2). The diagnosis of one seropositive subject (n:o #6) did not 
change even after micro-CT evaluation (Table 1).
Surface area measurements. The surface area measurements were taken from each 3D biopsy model 
using rectangles of different size up to 1.00 mm2, if feasible, excluding areas with artifacts e.g. due to biopsy 
handling (Fig. 4). It was also possible, for example, to use a circular measurement area but, for the sake of consist-
ency rectangular selection was used with all samples. Regardless of the degree of mucosal damage, measurement 
rectangles with different basal areas provided consistent effective surface areas when applied to the same biopsy 
with side lengths ≥ 0.5 mm; with lengths < 0.5 mm uncertainty and differences from larger measurement sizes 
began to emerge and the selection of the mucosal site became more significant (Supplementary Fig. 2). Align-
ment of the measurement rectangle was easy and replicable (data not shown).
There was a logical relationship between the surface areas and corresponding VH:CrD (Table 1). More spe-
cifically, with a flat mucosa the surface area coefficient approached the theoretical minimum of 1.0, while the 
corresponding values of non-celiac controls and patients with a healed mucosa were 4.4–6.1. Furthermore, all 
cases with potential celiac disease in conventional histology, including case #6 with a normal VH:CrD even in 
the micro-CT evaluation, showed reduced surface area at baseline, and a subsequent increase of the area to the 
level of controls and cured patients on treatment (Table 1).
Discussion
We succeeded in developing a practical micro-CT imaging protocol for virtual 3D reconstruction of human-
derived intestinal biopsies. The method enabled fast and replicable digital cutting of the biopsies for precise 
digital morphometry. Notably, the amount of human labor required for the morphological measurements from 
3D images was only a fraction when compared with the average of standard histomorphometry. We believe that 
the novel approach can significantly improve the diagnostics of celiac disease, which currently involves many 
 challenges23. Particularly difficult in conventional histopathology is, as also demonstrated here, correct section-
ing of the biopsies for accurate microscopic  evaluation3,4,24. This is one of the main reasons why, even if quite 
replicable with normal villi and flat mucosa, traditional grouped classification exhibits substantial intra- and 
interobserver variations between these  extremities25,26. Due to increasing screening, such cases with inconclusive 
histology are becoming more  prevalent2,15,27. Quantitative morphometry may be more accurate in these circum-
stances, as special emphasis is placed on correct biopsy  orientation3. Nevertheless, this requires expertise and, 
despite laborious re-cuttings, often remains suboptimal. The 3D micro-CT model can be endlessly re-orientated, 
and the reader can gain an impression of the variability of the villi and identify technical artifacts. As a result, 
even in this proof-of-concept study, we were able to identify celiac disease in two subjects with non-diagnostic 
conventional histology. Their diagnoses were further confirmed by the presence of the correct genetics, positive 
mucosal IgA deposits and dietary  response15,19.
Besides diagnostics of celiac disease, another field in which better histological tools are needed is in treatment 
trials. There is an increasing demand for alternatives to the burdensome gluten-free diet, and accurate outcome 
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Figure 2.  Examples of 3D biopsy reconstructions and digitally cut sections from an untreated celiac disease 
patient diagnosed in routine practice (A), from a seropositive individual with duodenal morphology interpreted 
as normal (potential celiac disease, B), and from a non-celiac control subject with negative serology and normal 
villi (C). The image scaling is uniform throughout the figure. The 3D model allows free virtual orientation and 
rapid setting of an optimal cutting angle for precise digital morphometry. Although the biopsy in Panel B was 
originally interpreted as normal, possibly due to incorrect orientation or patchy mucosal lesion, the abnormal 
surface structure with widened and blunted villi can be readily seen in the 3D reconstruction; particularly when 
comparing with the longer villi in (C). The orientated digital section on the right side of the (B) confirms the 
decreased villous-crypt ratio characteristic of celiac disease. (C) Also demonstrates the variability in the villous 
morphology even in healthy mucosa. The structural differences seen in the middle of the image (right side of the 
panel) is only random variation that has no diagnostic significance.
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Figure 3.  Duodenal biopsies evaluated in routine practice with conventional histology (photos on the left), 
orientated sections investigated by quantitative histomorphometry (middle photos) and digital cuttings 
obtained via reconstructed micro-CT models (photos on the right). In patients 1–6 biopsies were also taken 
after approximately one year on a gluten-free diet (GFD). Patients 1–3 had received a celiac disease diagnosis, 
subjects 4–6 had positive celiac disease serology but were originally considered to have normal villi (potential 
celiac disease) and subjects 7–8 exemplify non-celiac controls with negative serology and normal histology. 
Numbering of the patients and samples corresponds Table 1.
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measures are critical for the required  trials7,28. Histology remains the gold standard, as mucosal healing is a 
prerequisite for a treatment to be effective, and the current non-invasive surrogate markers lack the necessary 
 sensitivity7,28,29. Recently developed innovative immunological outcome measurements, such as HLA-DQ-gluten 
tetramer  test30, are promising but require further  validation7. The problem with conventional histology is, again, 
the poor geometrical accuracy and replicability, particularly with the minor changes seen during short-term 
gluten challenge studies. This is the case even with morphometry, as the early damage is often patchy and variable 
even within the same  biopsy7. The situation differs from diagnostic evaluation, in which the most damaged area 
is sought, whereas in prospective studies replicability of the histology is more important. This further emphasizes 
the benefits of micro-CT, as the correct cutting angle can be selected individually from several villi, which reduces 
the risk of random variation and inaccuracy caused e.g. by twisted biopsy.
As an entirely novel approach, we succeeded in analyzing the mucosal surface area. Although confirmation in 
larger series is needed, the technique seemed to offer excellent accuracy and replicability, as well as to correlate 
logically with other disease parameters. This, together with the small variation in the results between different 
measurement rectangle sizes and positions on the same biopsy, concurs with the theoretical premise that sur-
face area is a more consistent outcome than (even optimized) cross-sectional  evaluation2. It could also yield a 
more precise estimate of the intestinal absorption capacity. In fact, inaccuracy in conventional histology may 
explain the previously reported poor correlation between the degree of enteropathy and clinical  presentation31. 
Interestingly, the surface structure seen in the digital 3D image of a patient with potential CD (Fig. 2) appears 
to be visually very different compared to the control patient and arouses a suspicion of mucosal damage. This 
perhaps diagnostically significant factor could only be detectable with a 3D image. The superior sensitivity of 
Figure 4.  Demonstration of the surface area measurement from the digital 3D models of the small-bowel 
mucosal biopsies by computer-assisted point cloud analysis (Avizo software; Thermo Fisher Scientific, Waltham, 
MA, USA). The image scaling is uniform throughout the figure. Panel (A) represents morphologically normal 
mucosa from a non-celiac individual and Panel (B) advanced celiac disease with almost flat mucosa. For the 
measurements, a rectangle of pre-defined size is aligned with the mucosa and the surface area is calculated 
within these boundaries. It is possible to use different rectangular side lengths and various measurement shapes. 
Use of equal image resolution and noise filtering is required for consistent results. The surface area in Panel (A) 
was 5.973 mm2 and in Panel (B) 1.548 mm2 when applying a measurement rectangle with an area of 1.000 mm2. 
Black bar = 1.0 mm.
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3D measurement is also in agreement with the reduced surface area in the one subject who had gluten-sensitive 
symptoms but normal cross-sectional VH:CrD even with micro-CT. Altogether, the novel approach offers intrigu-
ing possibilities for the diagnostics of celiac disease and as a novel outcome for the abovementioned drug trials. 
Surface area measurement could also be utilized e.g. when investigating safe levels of residual  gluten32, to confirm 
diagnosis in individuals with a self-initiated gluten-free diet and in the diagnostics of other disorders involving 
duodenal  abnormalities33.
Some caution, however, is needed when interpreting the results. For example, it must be born in mind that 
reduced surface area is not the only reason for impaired intestinal absorption, as there may also, for example, 
be disturbances in the cell differentiation and vascular organization of the  epithelium34,35. Interestingly, in the 
future micro-CT may also be utilized to quantify these more subtle histological  changes36. Certain technical 
issues may also affect the measurements, including variable architecture of the biopsy surfaces, perhaps due to 
merging of the villi to form complex structures possibly displaying reduced surface area with normal VH:CrD. 
This phenomenon was already reported in the  1960s37,38, but has been largely ignored. It is currently unclear 
whether such changes represent variable stages of mucosal damage, or merely morphological variation along 
the length of the intestine and/or between  individuals37,39. These disparities may also explain the somewhat 
unequal surface areas we observed between the non-celiac individuals here. Larger series of patients with diverse 
clinicopathologic features are needed to further elucidate these issues.
Limitations of the study. The lower resolution of micro-CT reconstructions compared with conventional 
histology could theoretically affect the diagnostic accuracy, but this drawback is outweighed by the optimal 
biopsy orientation. We were unable to measure the degree of mucosal inflammation, which, although unspecific, 
is considered an integral part of the differential diagnostics of duodenal  diseases33. This information might be 
obtainable utilizing X-ray contrast agents with specific  ligands40 targeting e.g. CD3+ intraepithelial lymphocytes. 
As it was completely novel approach, calculation of the surface areas was done partly manually, but it should be 
fairly straightforward to automatize this  process41. It was also not reasonable to calculate precise intra- and inter-
observer variations for micro-CT imaging in this proof-of-concept study, and these remain to be determined. Of 
note, the sample-specific imaging time could likely be decreased by reducing the number of projections from the 
1,600 used here as recommended by the device manufacturer to ensure successful surface area analyzes. Further 
studies in this field should be conducted in various patient series. However, the actual imaging time is usually 
not a time limiting factor in clinical practice, as the results are not needed urgently and this is not an expensive 
labor-requiring step of the analysis. Finally, the method requires technical expertise and relatively expensive 
equipment, thus restricting its clinical use. Then again, it is quite easy to ship paraffin-embedded biopsies to 
specialized centers for micro-CT studies.
conclusions
The 3D micro-CT imaging of stained biopsies provided good contrast and precise morphometric measurement 
of the small-bowel mucosa in endoscopically obtained biopsies, readily demonstrated by the altered diagnosis 
of some patients already in this proof-of-concept study. The improved accuracy and replicability of the histo-
pathological evaluation, together with the possibility to measure biologically meaningful villous surface areas, 
offer a powerful tool for the diagnostics of celiac disease and for future prospective trials.
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